In yesterday’s Wall Street session, Haleon plc (NYSE:HLN) shares traded at $7.93, up 0.63% from the previous session.
15 analysts cover Haleon plc (NYSE:HLN), according to research data. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $4.00 and a low of $2.50, we find $3.35. Given the previous closing price of $7.88, this indicates a potential downside of -57.49 percent. HLN stock price is now -0.12% away from the 50-day moving average and 12.53% away from the 200-day moving average. The market capitalization of the company currently stands at $36.15B.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
The stock has received a hold rating from 4 analysts and a buy rating from 8. Brokers who have rated the stock have averaged $3.38 as their price target over the next twelve months.
.
A total of 6.41% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in HLN stock. A new stake in Haleon plc shares was purchased by SOUTHPOINT CAPITAL ADVISORS LP during the first quarter worth $49,166,000. ALLIANCEBERNSTEIN L.P. invested $48,532,000 in shares of HLN during the first quarter. In the first quarter, EMINENCE CAPITAL, LP acquired a new stake in Haleon plc valued at approximately $25,548,000. POINT72 ASSET MANAGEMENT, L.P. acquired a new stake in HLN for approximately $18,375,000. MANE GLOBAL CAPITAL MANAGEMENT LP purchased a new stake in HLN valued at around $18,192,000 in the second quarter. In total, there are 613 active investors with 6.70% ownership of the company’s stock.
On Monday morning Haleon plc (NYSE: HLN) stock kicked off with the opening price of $7.91. During the past 12 months, Haleon plc has had a low of $5.59 and a high of $8.50. As of last week, the company has a debt-to-equity ratio of 0.14, a current ratio of 3.40, and a quick ratio of 3.20. The fifty day moving average price for HLN is $7.95 and a two-hundred day moving average price translates $7.04 for the stock.
The latest earnings results from Haleon plc (NYSE: HLN) was released for Sep, 2022.
Moreover, the firm recently paid out its quarterly dividend on 04/27/2023. Investors who held shares on 03/17/2023 were paid a $0.0577344 dividend. On an annualized basis, this represents a $0.12 dividend and a 1.46% percent yield. There was an ex-dividend date of 03/16/2023 for this dividend.
Haleon plc(HLN) Company Profile
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands includes Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
